Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world-Reference-Cited by-同舟云学术

Progressive multifocal leukoencephalopathy with natalizumab extended or standard interval dosing in the United States and the rest of the world

Published:2023-06-10 Issue:10 Volume:22 Page:995-1002
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Dsilva Liesel¹,McCarthy Kerry²,Lyons Jennifer¹,Cabigas Bernadette¹,Campbell Nolan³,Kong George⁴,Adams Bryan⁴,Kuhelj Robert⁵,Singhal Priya⁶,Smirnakis Karen⁷

Affiliation:

1. Global Medical Safety, Biogen, Cambridge, MA, USA

2. Drug Safety, Pharmacovigilance & Systems & Data Analytics, Biogen, Cambridge, MA, USA

3. Global Medical, Biogen, Cambridge, MA, USA

4. Biostatistics, Biogen, Cambridge, MA, USA

5. Global Medical, Biogen, Baar, Switzerland

6. Development, Biogen, Cambridge, MA, USA

7. Safety and Benefit Risk Management, Biogen, Cambridge, MA, USA

Funder

Biogen

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2221027

Reference32 articles.

1. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

2. Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)

3. Natalizumab in early relapsing-remitting multiple sclerosis: a 4-year, open-label study;Perumal J;Adv Ther,2021

4. Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

5. Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following Natalizumab-Associated Progressive Multifocal Leukoencephalopathy;Neurology Clinical Practice;2024-10

2. Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases;Neuroimaging Clinics of North America;2024-08

3. Revisiting JC virus and progressive multifocal leukoencephalopathy;Journal of NeuroVirology;2023-09-02